Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview

A. G. Randolph and E. E. Wang
Department of Pediatrics, University of California, San Francisco, USA.

OBJECTIVE: To systematically review the evidence evaluating the efficacy of aerosolized ribavirin for the treatment of infants with respiratory syncytial virus lower respiratory tract infection. DESIGN: A computerized search of MEDLINE from 1975 to the present, a review of the reference lists of each retrieved article, and contact with experts. PATIENTS: infants with documented respiratory syncytial virus lower respiratory tract infection who were the subjects of 8 double-blind randomized placebo-controlled trials. METHODS: Two independent reviewers assessed study quality and extracted data on the study populations, the drug regimens, and clinically relevant outcome measurements. RESULTS: Ribavirin does not significantly reduce mortality rate (relative risk [RR] = 0.42, 95% confidence interval [CI] = 0.13, 1.44) or lower the probability of respiratory deterioration (RR = 0.42, 95% CI = 0.16, 1.34) when meta-analysis is used to pool the outcomes of 3 trials, although strong trends in the direction of benefit are present. No study found ribavirin to shorten length of hospitalization. Results on length of ventilation and oxygen supplementation are conflicting. CONCLUSIONS: Use of ribavirin in infants with respiratory syncytial virus lower respiratory tract infection is not supported by evidence of significant benefit. However, previous studies lack sufficient power to rule out a potential reduction in mortality rate or respiratory deterioration. A large randomized controlled trial of ribavirin for ventilated and other high-risk patients is needed.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lower Respiratory Viral Illnesses: Improved Diagnosis by Molecular Methods and Clinical Impact
Garbino et al.
Am. J. Respir. Crit. Care Med. 2004;170:1197-1203.
ABSTRACT | FULL TEXT  

Animal Pneumoviruses: Molecular Genetics and Pathogenesis
Easton et al.
Clin. Microbiol. Rev. 2004;17:390-412.
ABSTRACT | FULL TEXT  

The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management
Anaissie et al.
Blood 2004;103:1611-1617.
ABSTRACT | FULL TEXT  

Diagnosis and Testing in Bronchiolitis: A Systematic Review
Bordley et al.
Arch Pediatr Adolesc Med 2004;158:119-126.
ABSTRACT | FULL TEXT  

Pharmacologic Treatment of Bronchiolitis in Infants and Children: A Systematic Review
King et al.
Arch Pediatr Adolesc Med 2004;158:127-137.
ABSTRACT | FULL TEXT  

Altered Pathogenesis of Severe Pneumovirus Infection in Response to Combined Antiviral and Specific Immunomodulatory Agents
Bonville et al.
J. Virol. 2002;77:1237-1244.
ABSTRACT | FULL TEXT  

Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases
Wennergren and Kristjansson
Eur Respir J 2001;18:1044-1058.
ABSTRACT | FULL TEXT  

Uncertainty in the Management of Viral Lower Respiratory Tract Disease
Meissner
Pediatrics 2001;108:1000-1003.
FULL TEXT  

Effect of RSV Bronchiolitis Practice Guidelines on Resource Utilization
Harrison et al.
CLIN PEDIATR 2001;40:489-495.
ABSTRACT  

New treatments for viral respiratory tract infections--opportunities and problems
Snell
J Antimicrob Chemother 2001;47:251-259.
FULL TEXT  

Exogenous Surfactant Supplementation in Infants with Respiratory Syncytial Virus Bronchiolitis
TIBBY et al.
Am. J. Respir. Crit. Care Med. 2000;162:1251-1256.
ABSTRACT | FULL TEXT  

Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment
Domachowske and Rosenberg
Clin. Microbiol. Rev. 1999;12:298-309.
ABSTRACT | FULL TEXT  

Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing
Fox et al.
Arch. Dis. Child. 1999;80:343-347.
ABSTRACT | FULL TEXT  

Reducing the Morbidity of Lower Respiratory Tract Infections Caused by Respiratory Syncytial Virus: Still No Answer
Russell et al.
Pediatrics 1997;99:472-472.
FULL TEXT  

RIBAVIRIN NOT EFFECTIVE FOR INFANT RSV INFECTION
JWatch General 1996;1996:5-5.
FULL TEXT